Angioimmunoblastic Lymphadenopathy With Dysproteinemia - 244 Studies Found
Terminated |
: Ipilimumab and Local Radiation Therapy in Treating Patients With Recurrent Melanoma, Non-Hodgkin Lymphoma, Colon, or Rectal Cancer :
: |
Completed |
: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma :
: |
Active, not recruiting |
: Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies :
: |
Completed |
: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies :
: |
Completed |
: Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma :
: |
Terminated |
: Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant :
: |
Active, not recruiting |
: Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma :
: |
Completed |
: Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma :
: |
Active, not recruiting |
: AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma :
: |
Completed |
: Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma :
: |